自体外周血干细胞移植治疗乙型肝炎肝硬化患者临床疗效及其对外周血T淋巴细胞亚群的影响

doi:10.3969/j.issn.1672-5069.2019.01.026

摘要/Abstract

摘要： 目的研究应用自体外周血干细胞（PBSC）移植治疗乙型肝炎肝硬化患者的临床疗效及其对外周血T淋巴细胞亚群的影响。方法 2014年4月~2017年4月我院收治的乙型肝炎肝硬化患者95例,被随机分为移植组48例和对照组47例。两组均接受护肝、降酶和恩替卡韦抗病毒治疗,另48例患者再接受自体PBSC经肝动脉移植治疗。使用流式细胞仪检测外周血T细胞亚群,使用Fibroscan扫描仪检测肝脏硬度,采用ELISA法检测血清肿瘤坏死因子（TNF-α）和白细胞介素-6 （IL-6）,采用免疫透射比浊法检测血清超敏C反应蛋白（hs-CRP）。结果在治疗后6 m,移植组患者血清总胆红素（TBIL）水平为（16.4±1.2） μmol/L,显著低于对照组的（22.5±2.6） μmol/L（P<0.05）,血清白蛋白（ALB）水平为（35.2±4.0） g/L,显著高于对照组的（31.6±3.7） g/L（P<0.05）;移植组外周血CD3⁺细胞百分比为（67.9±6.5） %,显著高于对照组的【（60.3±5.5） %,P<0.05】,CD4⁺为（42.7±3.8） %,显著高于对照组的【（38.2±3.5） %,P<0.05】,CD4⁺/ CD8⁺细胞比值为（1.5±0.2）,显著高于对照组的【（1.4±0.1）,P<0.05】;移植组肝硬度值为（7.1±0.1）kPa,显著低于对照组[（7.9±0.1） kPa,P<0.05],Child-Pugh评分为（5.5±1.5）,显著低于对照组[（7.4±2.3）,P<0.05];移植组血清TNF-α水平为（28.0±8.7） pg/mL,显著低于对照组[（36.2±8.6）pg/mL,P<0.05], IL-6水平为（6.0±2.2） mg/L,显著低于对照组[（8.7±3.5） mg/L,P<0.05], hs-CRP水平为（18.9±5.6） pg/mL,显著低于对照组[（25.2±7.9） pg/mL,P<0.05]。结论自体外周血干细胞移植治疗乙型肝炎肝硬化患者近期疗效较好,能有效降低血清细胞因子水平,改善肝功能。

关键词: 肝硬化, 外周血干细胞移植, T淋巴细胞亚群, 细胞因子, 疗效

Abstract: Objective To investigate the clinical efficacy of autologous peripheral blood stem cell （PBSC） transplantation in patients with hepatitis B cirrhosis. Methods 95 patients with hepatitis B liver cirrhosis were recruited in our Department of Infectious Diseases between April 2014 and April 2017,and all the patients were randomly divided into transplantation （n=48） and control group （n=47）. The patients in the control group received entecavir and conventional supporting treatment,and the patients in the observation group were treated with intrahepatic transplantation of autologous PBSCs via hepatic artery at the base of supporting treatment. Peripheral blood T lymphocyte subgroups,liver stiffness,and serum tumor necrosis factor-α（TNF-α）,interleukin-6 （IL-6） and hypersensitive C reactive protein（hs-CRP） levels were assayed. Results At the end of 6 month treatment,total serum bilirubin level in patients receiving PBSCs transplantation was（16.4±1.2） μmol/L,significantly lower than （22.5±2.6） μmol/L （P<0.05） in the control,while serum albumin level was （35.2±4.0） g/L,much higher than （31.6±3.7） g/L（P<0.05） in the control;the percentage of peripheral blood CD3⁺ cells was （67.9±6.5）%,significantly higher than 【（60.3±5.5）%,P<0.05】,CD4⁺ cells was （42.7±3.8）%,significantly higher than 【（38.2±3.5）%,P<0.05】,and ratio of CD4⁺/ CD8⁺ cells was （1.5±0.2）,significantly higher than 【（1.4±0.1）,P<0.05】 in the control;the liver stiffness measurement was （7.1±0.1） kPa,much lower than [（7.9±0.1）kPa,P<0.05],and Child-Pugh score was （5.5±1.5）,much lower than [（7.4±2.3）,P<0.05] in the control;serum hs-CRP level was （18.9±5.6） pg/mL,much lower than [（25.2±7.9） pg/mL,P<0.05] in the control. Conclusion Autologous stem cell transplantation is short-term efficient in patients with hepatitis B liver cirrhosis,which might effectively improve the patient's immune functions,and decrease the blood cytokine levels.

Key words: Liver cirrhosis, Autologous peripheral blood stem cell transplantation, Lymphocyte subsets, Cytokines, Efficacy

王禅, 秦伟, 戴勇, 李晓峰, 张成强. 自体外周血干细胞移植治疗乙型肝炎肝硬化患者临床疗效及其对外周血T淋巴细胞亚群的影响[J]. 实用肝脏病杂志, 2019, 22(1): 97-100.

Wang Chan, Qin Wei, Dai Yong, et al.. Clinical efficacy of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 97-100.

参考文献

[1] Hoskote SS,Reddy DR,Onigkeit JA.Precipitation of ventricular bigeminy by DMSO during autologous haematopoietic stem cell transplantation. Transfus Med,2015,25(2):118-121.
[2] Shahera U,Munshi S,Jahan M,et al.IP-10,p53,and Foxp3 expression in hepatocytes of chronic hepatitis B patients with cirrhosis and hepatocellular carcinoma. Euroasian J Hepatogastroenterol,2016,6(2):149-153.
[3] 王方,杨兴坤,寇俊峰,等. 替比夫定治疗HBeAg阳性慢性乙型肝炎和肝硬化患者血清免疫球蛋白和补体水平的变化. 实用肝脏病杂志,2015,18(6):672-673.
[4] Mahtab MA, Rahim A, Mohammad Noor-E-Alam S ,et al. A case report of decompensated cirrhosis of liver with sideroblastic anemia. Euroasian J Hepatogastroenterol,2015,5(1):55-56.
[5] Sreng B,Kimcheng H,Sovann LY,et al.Epidemiology of viral hepatitis and liver diseases in cambodia. Euroasian J Hepatogastroenterol,2015,5(1):30-33.
[6] Haque MS,Sultana S,Mahtab MA,et al.The value of serum CA19-9 levels in predicting extent of hepatic fibrosis in patients with chronic hepatitis B. Euroasian J Hepatogastroenterol,2015,5(1):16-18.
[7] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ.
[8] Moehler TM,Merz M,Kellermann L,et al.Diagnostic and therapeutic approaches to multiple myeloma patients:‘Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011. Oncol Lett,2016,12(6):5043-5051.
[9] Park CH,Bae SH,Kim HY,et al.A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure. Cytotherapy,2013,15(12):1571-1579.
[10] Liao X, AnCheng JY, Zhou QJ, et al. Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis. Hepatogastroenterology,2013,60(123):406-409.
[11] 臧志栋,田玉岭,傅熙玲. 阿德福韦酯治疗乙型肝炎肝硬化疗效分析. 实用肝脏病杂志,2012,15(5):445-446.
[12] Puri P.Acute exacerbation of chronic hepatitis B:the dilemma of differentiation from acute viral hepatitis B. J Clin Exp Hepatol,2013,3(4):301-312.
[13] Liu L,Yan Y,Zhou J,et al.Curative effect of combined lamivudine,adefovir dipivoxil, and stem cell transplantation on decompensated hepatitis B cirrhosis. Genet Mol Res,2014,13(4):9336-9342.
[14] Jieanu CF,Ungureanu BS, Sandulescu DL,et al.Quantification of liver fibrosis in chronic hepatitis B virus infection. J Med Life,2015,8(3):285-290.
[15] Bo J,Zhao Y,Zhang S,et al.Long-term outcomes of peripheral blood stem cell transplantation for 38 patients with peripheral T-cell lymphoma. J Cancer Res Ther,2016,12(3):1189-1197.
[16] Kayal S,Sharma A,Iqbal S,et al.High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma:a single institution experience at all India institute of medical sciences,New Delhi,using non-cryopreserved peripheral blood stem cells. Clin Lymphoma Myeloma Leuk,2014,14(2):140-147.
[17] Inano S,Iwasaki M,Iwamoto Y,et al.Impact of high-dose chemotherapy and autologous transplantation as first-line therapy on the survival of high-risk diffuse large B cell lymphoma patients:a single-center study in Japan. Int J Hematol,2014,99(2):162-168.
[18] Yeral M,Boga C, Oguzkurt L,et al.Tunnelled central venous catheter-related problems in the early phase of haematopoietic stem cell transplantation and effects on transplant outcome. Turk J Haematol,2015,32(1):51-57.
[19] Takahashi C,Nishi K,Minami-Hori M,et al.Multiple poromas following combination chemotherapy and autologous peripheral blood stem cell transplantation. J Dermatol,2015,42(4):430-432.
[20] Brioli A,Perrone G,Patriarca F,et al.Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation. Bone Marrow Transplant,2015,50(5):673-678.